Cliff Asness's PBH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 28,258 shares of Prestige Consumer Healthcare Inc. (PBH) worth $1.74 M, representing 0.00% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in PBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 247,001 shares. Largest reduction occurred in Q1 2021, reducing 298,900 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Prestige Consumer Healthcare (PBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Prestige Consumer Healthcare (PBH) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +4,142 | Add 17.18% | 28,258 | $61.69 |
| Q3 2025 | +3,088 | Add 14.69% | 24,116 | $61.89 |
| Q2 2025 | -9,028 | Reduce 30.04% | 21,028 | $79.85 |
| Q1 2025 | +3,200 | Add 11.92% | 30,056 | $85.12 |
| Q4 2024 | -3,780 | Reduce 12.34% | 26,856 | $77.63 |
| Q3 2024 | -1,767 | Reduce 5.45% | 30,636 | $71.13 |
| Q2 2024 | -1,027 | Reduce 3.07% | 32,403 | $68.85 |
| Q1 2024 | -4,344 | Reduce 11.50% | 33,430 | $72.56 |
| Q4 2023 | -10,467 | Reduce 21.70% | 37,774 | $61.22 |
| Q3 2023 | -552 | Reduce 1.13% | 48,241 | $57.19 |
| Q2 2023 | -9,820 | Reduce 16.75% | 48,793 | $59.43 |
| Q1 2023 | -15,059 | Reduce 20.44% | 58,613 | $62.28 |
| Q4 2022 | -5,649 | Reduce 7.12% | 73,672 | $62.60 |
| Q3 2022 | +17,040 | Add 27.36% | 79,321 | $49.84 |
| Q2 2022 | +4,536 | Add 7.86% | 62,281 | $56.57 |
| Q1 2022 | +6,834 | Add 13.42% | 57,745 | $52.94 |
| Q4 2021 | +12,560 | Add 32.75% | 50,911 | $60.65 |
| Q3 2021 | -3,376 | Reduce 8.09% | 38,351 | $56.11 |
| Q2 2021 | -59,110 | Reduce 58.62% | 41,727 | $52.10 |
| Q1 2021 | -298,900 | Reduce 74.77% | 100,837 | $43.59 |
| Q4 2020 | -74,296 | Reduce 15.67% | 399,737 | $34.87 |
| Q3 2020 | +89,767 | Add 23.36% | 474,033 | $35.85 |
| Q2 2020 | +247,001 | Add 179.94% | 384,266 | $37.07 |
| Q1 2020 | +125,342 | Add 1051.26% | 137,265 | $36.48 |
| Q4 2019 | +4,817 | Add 67.79% | 11,923 | $40.51 |
| Q3 2019 | +7,106 | New Buy | 7,106 | $34.76 |
| Q4 2018 | -9,928 | Sold Out | 0 | $0.00 |
| Q3 2018 | -39,443 | Reduce 79.89% | 9,928 | $37.87 |
| Q2 2018 | +49,371 | New Buy | 49,371 | $38.38 |
| Q2 2017 | -17,413 | Sold Out | 0 | $0.00 |
| Q1 2017 | -17,510 | Reduce 50.14% | 17,413 | $55.53 |
| Q4 2016 | -34,578 | Reduce 49.75% | 34,923 | $52.09 |
| Q3 2016 | +3,078 | Add 4.63% | 69,501 | $48.27 |
| Q2 2016 | +36,555 | Add 122.39% | 66,423 | $55.40 |
| Q1 2016 | +3,447 | Add 13.05% | 29,868 | $53.40 |
| Q4 2015 | -1,881 | Reduce 6.65% | 26,421 | $51.47 |
| Q3 2015 | +202 | Add 0.72% | 28,302 | $45.16 |
| Q2 2015 | +14,167 | Add 101.68% | 28,100 | $46.23 |
| Q1 2015 | +13,933 | New Buy | 13,933 | $42.92 |
| Q4 2014 | -22,842 | Sold Out | 0 | $0.00 |
| Q3 2014 | +1,600 | Add 7.53% | 22,842 | $32.35 |
| Q2 2014 | -42,509 | Reduce 66.68% | 21,242 | $33.90 |
| Q1 2014 | -49,200 | Reduce 43.56% | 63,751 | $27.25 |
| Q4 2013 | -16,900 | Reduce 13.01% | 112,951 | $35.80 |
| Q3 2013 | -116,891 | Reduce 47.37% | 129,851 | $30.12 |
| Q2 2013 | +246,742 | Add 0.00% | 246,742 | $29.14 |
| Q4 2012 | +239,142 | Add 0.00% | 239,142 | $20.03 |
Cliff Asness's Prestige Consumer Healthcare Investment FAQs
Cliff Asness first purchased Prestige Consumer Healthcare Inc. (PBH) in Q4 2012, acquiring 239,142 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Prestige Consumer Healthcare Inc. (PBH) for 48 quarters since Q4 2012.
Cliff Asness's largest addition to Prestige Consumer Healthcare Inc. (PBH) was in Q2 2020, adding 384,266 shares worth $14.24 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 28,258 shares of Prestige Consumer Healthcare Inc. (PBH), valued at approximately $1.74 M.
As of the Q4 2025 filing, Prestige Consumer Healthcare Inc. (PBH) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Prestige Consumer Healthcare Inc. (PBH) was 474,033 shares, as reported at the end of Q3 2020.